p53-p66shc/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma
- 1 November 2015
- journal article
- Published by Elsevier BV in Toxicology Letters
- Vol. 238 (3), 1-10
- https://doi.org/10.1016/j.toxlet.2015.07.016
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in TaiwanHepatology, 2013
- Role of MnSOD and p66shc in Mitochondrial Response to p53Antioxidants and Redox Signaling, 2011
- Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and AngiogenesisCancer Research, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Mouse Models of Hepatocellular CarcinomaSeminars in Liver Disease, 2010
- A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinomaHepatology, 2009
- The mitochondrial p53 pathwayBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial ApoptosisCell, 2005
- SUPEROXIDE RADICAL AND SUPEROXIDE DISMUTASESAnnual Review of Biochemistry, 1995
- SOD2: A new type of tumor‐suppressor gene?International Journal of Cancer, 1992